ShiraTronics has filed a notice of an exempt offering of securities to raise $66,008,867.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, ShiraTronics is raising up to $66,008,867.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Robert Binney played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About ShiraTronics
ShiraTronics is working to develop new innovative therapies to combat debilitating chronic migraine headache. We are focused on commercializing novel neuromodulation technologies for this large unmet clinical need. Our mission is to transform the lives of those living with Chronic Migraine. When medications don’t reduce the frequency and/or severity of chronic migraine attacks, neuromodulation may be an effective solution.
To learn more about ShiraTronics, visit http://shiratronics.com/
ShiraTronics Linkedin Page: https://www.linkedin.com/company/shiratronics-inc/
Contact:
Robert Binney, Chief Executive Officer
763-772-2313
https://www.linkedin.com/in/rob-binney-67219939/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.